Webinars
At ICR Westwicke, we partner with industry thought leaders to bring you webinars that are relevant to investor relations, IPO advisory, capital markets, and more.
Featured Webinars:
Understanding the Continued SPAC Surge
SPAC (special purpose acquisition company) transactions set records in 2020 with more than 200 SPACs raising roughly $80B. They have emerged as a viable alternative to traditional IPOs while also providing retail investors exposure to Private Equity deal flow. How do you go about understanding the intricacies of this market? View Webinar
PIPE and Other Capital Raising Transactions in Connection with De-SPACing
With the increase in special purpose acquisition company (SPAC) deals, it’s important to understand the transactions that come along with the de-SPACing process. In this webinar, learn about capital-raising options, including PIPE transactions, forward purchase transactions, and private placements with the SPAC sponsor affiliates. View Webinar
Boot Camp: IPOs, SPACs, and Direct Listings
Companies aiming to go public now have options beyond a traditional IPO, including SPAC transactions and direct listings. In this webinar, a panel of experts discuss these listing options, the preparation process for a new listing, and an assessment of the current market. View Webinar
Life Sciences and Healthcare SPACs: An Alternate Pathway to Going Public
Special purpose acquisition companies (SPACs) have been making significant headlines in 2020. As SPACs increasingly focus on the life sciences and healthcare industry, many companies are wondering if they should consider a SPAC transaction as an alternative to a traditional IPO. In this webinar, panelists discuss considerations around SPAC transactions. View Webinar
The Virtual IPO: How IPOs Are Changing
The past several months have created more change in the IPO market than the last 25 to 30 years. In this webinar hosted by ICR Capital and Davis Polk, experts discussed what they’ve seen in the IPO market recently, changes to standard IPO processes, and what’s to come for IPOs during the remainder of the year. View Webinar
International Biotech: Accessing the U.S. Capital Markets in a Post-COVID-19 World
Through the coronavirus pandemic, biotech companies have continued to innovate. Many international companies have now turned to U.S. capital markets to finance that vision and innovation. In this webinar hosted by the New York Stock Exchange, a panel of capital markets and biotech experts discussed updates in today’s rapidly changing environment. View Webinar
IPO Summit Webinar
As the capital markets gradually recover, companies are beginning to plan for IPOs. In this webinar hosted by ICR and IPO Edge, a panel of experts discussed considerations around IPO planning and readiness, corporate governance, and more. View Webinar
Wall Street Revealed: How Does the Sell-Side Really Look at Companies?
Whether you’re a private or public company, this webinar provides insight on how the sell-side thinks about companies they cover, how they prefer to be communicated with, and other vital knowledge to help you navigate today’s marketplace. Here, we partner with Deutsche Bank, Piper Jaffray, and Stifel to discuss how to bolster and yield results from your sell-side strategy. View Webinar